Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-052277

COO & Chief Financial Officer sold 22,000 shares at an average $95.31 ($2,096,779)

  • COO & Chief Financial Officer acquired 52,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LOWE CHRISTOPHER P. · COO & Chief Financial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-16 Exercise or conversion : show line 1 in the form +22,000 $2.23 $49,060 52,000 D
2021-08-16 Sale : show line 2 in the form −9,158 $94.23 $862,958 42,842 D
2021-08-16 Sale : show line 3 in the form −7,335 $95.02 $696,972 35,507 D
2021-08-16 Sale : show line 4 in the form −2,330 $96.32 $224,426 33,177 D
2021-08-16 Sale : show line 5 in the form −1,100 $97.28 $107,008 32,077 D
2021-08-16 Sale : show line 6 in the form −2,077 $98.90 $205,415 30,000 D
2021-08-17 Exercise or conversion : show line 7 in the form +30,000 $2.23 $66,900 60,000 D
Open-market sales · 22,000 sh · avg $95.31 · $2,096,779

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-08-16 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −22,000 163,294 D
2021-08-17 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −30,000 133,294 D
Loading xslF345X03/doc4.xml…